Key terms
About DH
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. Its solution offers information on healthcare providers and their activities to help the customers optimize from product development to go-to-market planning, sales, and marketing execution. The company was founded by Jason Kranzt in February 2011 and is headquartered in Framingham, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest DH news
May 10
1:36am ET
Hold Rating Justified by Mixed Financial Performance and Uncertain Outlook for Definitive Healthcare Corp
May 09
9:00am ET
Definitive Healthcare price target lowered to $7 from $10 at Deutsche Bank
May 09
4:58am ET
Definitive Healthcare price target lowered to $7 from $11 at Barclays
May 09
3:29am ET
Barclays Keeps Their Hold Rating on Definitive Healthcare Corp (DH)
May 08
10:20pm ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
May 08
1:40pm ET
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Avadel Pharmaceuticals (AVDL)
May 08
1:23pm ET
Definitive Healthcare price target lowered to $7 from $10 at Deutsche Bank
May 08
7:49am ET
Definitive Healthcare price target lowered to $8 from $10 at Canaccord
May 08
4:59am ET
Definitive Healthcare downgraded to Equal Weight from Overweight at Morgan Stanley
May 07
5:06pm ET
Definitive Healthcare sees FY24 EPS 36c-38c, consensus 38c
May 07
5:04pm ET
Definitive Healthcare reports Q1 EPS (8c), consensus 8c
Apr 16
9:04am ET
Definitive Healthcare launches Carevoyance sales enablement solution
Mar 21
5:45am ET
Needham Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)
Mar 21
4:55am ET
Definitive Healthcare management to meet virtually with Needham
Mar 13
2:48pm ET
Definitive Healthcare management to meet virtually with Needham
Mar 01
5:29am ET
Definitive Healthcare price target raised to $11 from $10 at Barclays
Mar 01
2:56am ET
Barclays Keeps Their Hold Rating on Definitive Healthcare Corp (DH)
Mar 01
1:19am ET
Hold Rating on Definitive Healthcare Amid Leadership Changes and Revenue Uncertainties
Feb 29
10:25pm ET
Definitive Healthcare Corp.: A Stable Outlook with Limited Growth Justifying a Hold Rating
Feb 29
8:18am ET
Stifel Nicolaus Reaffirms Their Buy Rating on Definitive Healthcare Corp (DH)
Feb 29
7:56am ET
Maintaining Hold on Definitive Healthcare Corp Amidst Transition and Mixed Growth Signals
Feb 29
6:51am ET
Definitive Healthcare Corp: A Turnaround in Customer Retention and Margin Expansion Prompts Buy Rating
Feb 29
6:44am ET
Needham Sticks to Their Hold Rating for Definitive Healthcare Corp (DH)
No recent press releases are available for DH
DH Financials
Key terms
Ad Feedback
DH Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
DH Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range